Questran and Fenofibrate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Questran (cholestyramine) and Fenofibrate (fenofibrate). Common drug interactions include alanine aminotransferase increased among females and asthenia among males.
The phase IV clinical study analyzes what interactions people have when they take Questran and Fenofibrate. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.
What is Questran?
Questran has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 4,490 Questran users. Check the latest studies of Questran.
What is Fenofibrate?
Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,457 Fenofibrate users. Check the latest studies of Fenofibrate.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
38 people who take Questran and Fenofibrate together, and have interactions are studied.

What are the common drug interactions of Questran and Fenofibrate, by gender? *:
female:
- Alanine aminotransferase increased
- Anion gap increased
- Asthenia (weakness)
- Bacterial infection
- Bacterial test positive
- Blood alkaline phosphatase increased
- Blood chloride increased
- Blood glucose decreased
- Brain injury
- Carbon dioxide decreased
male:
- Asthenia (weakness)
- Headache (pain in head)
- Anxiety
- Application site pruritus (application site severe itching of the skin)
- Application site rash
- Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
- Blood bilirubin increased
- Chest discomfort
- Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins)
- Chronic kidney disease
What are the common drug interactions of Questran and Fenofibrate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Pain
- Persecutory delusion
- Renal failure (kidney dysfunction)
- Stress
- Throat tightness
- Visual impairment
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Asthenia (weakness)
- Chronic kidney disease
50-59:
- Muscle cramps (painful sensations caused by muscle contraction)
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins)
- Malaise (a feeling of general discomfort or uneasiness)
- Metastatic lymphoma (spreadable cancer tumour of lymph node)
- Nausea (feeling of having an urge to vomit)
60+:
- Pyrexia (fever)
- Abdominal pain lower
- Drug level below therapeutic
- Drug level decreased
- Erythema (redness of the skin)
- Gait disturbance
- Groin pain
- Malaise (a feeling of general discomfort or uneasiness)
- Pain
- Pruritus (severe itching of the skin)
What are the existing conditions these people have? *
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 17 people, 44.74%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 10.53%
- High Blood Pressure: 3 people, 7.89%
- Stress And Anxiety: 2 people, 5.26%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 5.26%
- Diabetes: 2 people, 5.26%
- Depression: 2 people, 5.26%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Questran and Fenofibrate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Questran (4,490 reports)
- Fenofibrate (40,457 reports)
Browse all drug interactions of Questran and Fenofibrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Questran:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Fenofibrate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Questran and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fenofibrate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cholestyramine and fenofibrate (the active ingredients of Questran and Fenofibrate, respectively), and Questran and Fenofibrate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Clobazam and Aspirin drug interactions for boys aged 2-9 - 9 seconds ago
- Drug interactions of Diazepam and Celexa - 14 seconds ago
- Could Skyrizi cause Tendon Pain? - 18 seconds ago
- Drug interactions of Enalapril Maleate and Epclusa - 20 seconds ago
- Drug interactions of Venlafaxine Hydrochloride and Glipizide - 28 seconds ago
- Diflucan and Erythema Multiforme for Men aged 20-29 - 34 seconds ago
- Diflucan and Stevens Johnson Syndrome for Men aged 20-29 - 34 seconds ago
- Could Diphen cause Painful Respiration? - 34 seconds ago
- Diflucan and Toxic Epidermal Necrolysis for Men aged 20-29 - 34 seconds ago
- Diflucan and Stevens-Johnson Syndrome for Men aged 20-29 - 35 seconds ago